Clinical Trials Browser

Not yet recruiting × Observational × Triple Negative Breast Neoplasms × Clear all

Inflammation, Primary Ovarian Insufficiency, Triple Negative Breast Neoplasms

NCT07523789 2026-04-13

Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC

Not yet recruiting

201 enrolled

Breast

Triple Negative Breast Neoplasms

NCT06396754 2026-03-27

AIDOBE

Not yet recruiting

50 enrolled

Breast

Triple Negative Breast Neoplasms

NCT07332975 2026-01-12

ctDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC

Not yet recruiting

77 enrolled

Breast

Triple Negative Breast Neoplasms

NCT07246759 2025-11-24

NEUTROFLOW

Not yet recruiting

600 enrolled

BreastDermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

NCT06798506 2025-01-29

Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Triple-negative Breast Cancer

Not yet recruiting

300 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06448169 2024-06-07

Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer

Not yet recruiting

200 enrolled

Breast

Hypersensitivity, Triple Negative Breast Neoplasms

NCT06418139 2024-05-16

PEMCLOCK

Not yet recruiting

450 enrolled

Breast

Triple Negative Breast Neoplasms

NCT05769491 2023-03-15

Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials

Not yet recruiting

500 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

FERTILE

Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC

AIDOBE

ctDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC

NEUTROFLOW

Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Triple-negative Breast Cancer

Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer

PEMCLOCK

Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials